Abstract
Introduction: Autism Spectrum Disorder (ASD) is characterized by deficits in communication and social interaction. Despite lacking a definitive cure, multidisciplinary therapeutic and pharmacological approaches are employed to mitigate their symptoms. However, the potential side effects of conventional treatments drive the search for alternatives such as cannabis derivatives for symptom relief. Objective: to analyze the eficacia of cannabis derivatives in the treatment of ASD. Method: a search for information was carried out in the databases and search engines Pubmed, Embase, Google Scholar and SciELO. The inclusion criteria are oriented towards observational studies and clinical trials analyzing the effects of cannabis derivatives in individuals diagnosed with autism spectrum disorders. Results: the treatment of autism using cannabis oil derivatives has emerged as a contemporary research topic in the academic literature. Despite that several studies, including systematic reviews and double-blind clinical trials, have examined the benefits of cannabidiol (CBD) in individuals diagnosed with ASD. Conclusion: it is feasible to infer, based on the scientific papers reviewed in this study, that treatment of Autism Spectrum Disorder (ASD) with cannabis derivatives could be beneficial. However, the current evidence is limited, indicating the need for further research in this area
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call